Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$941M |
| 2 |
Duolingo
DUOL
|
+$479M |
| 3 |
MDLN
Medline Inc
MDLN
|
+$440M |
| 4 |
Mercado Libre
MELI
|
+$345M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$1.18B |
| 2 |
Cloudflare
NET
|
+$1.06B |
| 3 |
Shopify
SHOP
|
+$680M |
| 4 |
BioNTech
BNTX
|
+$668M |
| 5 |
Meta Platforms (Facebook)
META
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 28.38% |
| 2 | Technology | 25.51% |
| 3 | Communication Services | 18.13% |
| 4 | Healthcare | 9.12% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Albemarle
ALB
$15.5B
| $49.9M | 0.04% |
352,618
-8,011
| -2% | -$909K |
|
152
T. Rowe Price
TROW
$24.3B
| $49.4M | 0.04% |
482,941
-11,166
| -2% | -$1.15M |
|
153
Medtronic
MDT
$113B
| $45.6M | 0.04% |
475,074
-3,140
| -0.7% | -$305K |
|
154
Edwards Lifesciences
EW
$53.1B
| $44M | 0.04% |
516,311
-55,936
| -10% | -$4.59M |
|
155
American Superconductor
AMSC
$1.56B
| $43.4M | 0.04% |
1,506,841
+79,509
| +6% | +$3.44M |
|
156
Petrobras Class A
PBR.A
$105B
| $42.5M | 0.04% |
3,768,768
-5,047
| -0.1% | -$58.3K |
|
157
dLocal
DLO
$4.25B
| $42.4M | 0.04% |
2,996,660
+326,537
| +12% | +$4.61M |
|
158
Astera Labs
ALAB
$56.4B
| $42.1M | 0.04% |
252,913
+22,126
| +10% | +$3.7M |
|
159
Twist Bioscience
TWST
$7.76B
| $40.5M | 0.03% |
1,276,195
+13,456
| +1% | +$420K |
|
160
McDonald's
MCD
$194B
| $38.8M | 0.03% |
126,880
-3,654
| -3% | -$1.12M |
|
161
Transmedics
TMDX
$2.97B
| $38.5M | 0.03% |
316,473
+55,754
| +21% | +$7M |
|
162
Infosys
INFY
$50.9B
| $37.5M | 0.03% |
2,107,125
-637,069
| -23% | -$11M |
|
163
MP Materials
MP
$9.84B
| $36.2M | 0.03% |
717,292
-237,312
| -25% | -$15M |
|
|
SVM
164
Silvercorp Metals
SVM
$2.65B
| $35.2M | 0.03% |
+4,221,271
| New | +$30.7M |
|
165
Paychex
PAYX
$42.7B
| $34.1M | 0.03% |
304,062
-4,743
| -2% | -$555K |
|
166
Appian
APPN
$2.46B
| $33.3M | 0.03% |
941,106
-52,868
| -5% | -$1.88M |
|
167
Upstart Holdings
UPST
$3B
| $33.2M | 0.03% |
+758,929
| New | +$34.9M |
|
168
Progyny
PGNY
$2.23B
| $32.4M | 0.03% |
1,262,691
+5,489
| +0.4% | +$126K |
|
169
Procept Biorobotics
PRCT
$1.21B
| $32M | 0.03% |
1,015,978
+157,147
| +18% | +$5.21M |
|
170
Amplitude
AMPL
$1.49B
| $31.8M | 0.03% |
2,741,880
+59,984
| +2% | +$631K |
|
171
Monster Beverage
MNST
$90.6B
| $29.9M | 0.02% |
389,458
+60,665
| +18% | +$4.35M |
|
|
SKYT
172
DELISTED
SkyWater Technology
SKYT
| $28.4M | 0.02% |
1,564,775
-62,554
| -4% | -$1.09M |
|
173
Banco de Chile
BCH
$20.9B
| $27.8M | 0.02% |
732,470
-203,569
| -22% | -$7.22M |
|
174
LiveRamp
RAMP
$2.3B
| $27.6M | 0.02% |
939,961
-86,669
| -8% | -$2.49M |
|
175
IPG Photonics
IPGP
$3.76B
| $27.5M | 0.02% |
383,984
-23,288
| -6% | -$1.9M |
|
Similar funds
Baillie Gifford & Co's Q4 2025 Portfolio in Review
As of Q4 2025, Baillie Gifford & Co held 286 positions worth $120B, down 11% from $135B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Baillie Gifford & Co withdrew a net $4.33B in Q4 2025, closing 20 positions and reducing 159 holdings. Its most notable exit was Pinterest, an estimated $251M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 30% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Baillie Gifford & Co opened a new position in Medline Inc worth $437M.
- Baillie Gifford & Co's largest Q4 2025 buy was Medline Inc: 10,410,371 shares worth $437M.
- Baillie Gifford & Co added most to Axon Enterprise in Q4 2025, an estimated $941M increase.
- Baillie Gifford & Co's biggest Q4 2025 reduction was Datadog, cutting an estimated $1.18B.
- Baillie Gifford & Co fully exited Pinterest in Q4 2025, selling an estimated $251M.
- Baillie Gifford & Co's ten largest holdings make up 43% of its $120B portfolio in Q4 2025.
- Baillie Gifford & Co opened 21 new positions and closed 20 in Q4 2025.
- Baillie Gifford & Co's portfolio value fell 11% quarter-over-quarter to $120B.
Based on Baillie Gifford & Co's 13F filing for Q4 2025, filed 23 Jan 2026.